A detailed history of Fortem Financial Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Fortem Financial Group, LLC holds 24,700 shares of OGN stock, worth $391,495. This represents 0.15% of its overall portfolio holdings.

Number of Shares
24,700
Previous 24,434 1.09%
Holding current value
$391,495
Previous $467,000 21.2%
% of portfolio
0.15%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 06, 2025

BUY
$14.44 - $18.83 $3,841 - $5,008
266 Added 1.09%
24,700 $368,000
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $455,694 - $562,715
24,434 New
24,434 $467,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.03B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.